Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 423

1.

Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.

Powell G, Saunders M, Marson AG.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD007124. doi: 10.1002/14651858.CD007124.pub2. Review. Update in: Cochrane Database Syst Rev. 2014;2:CD007124.

PMID:
20091617
2.

Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.

Powell G, Saunders M, Marson AG.

Cochrane Database Syst Rev. 2014 Feb 3;(2):CD007124. doi: 10.1002/14651858.CD007124.pub3. Review. Update in: Cochrane Database Syst Rev. 2014;(12):CD007124.

PMID:
24488654
3.

Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.

Powell G, Saunders M, Rigby A, Marson AG.

Cochrane Database Syst Rev. 2014 Dec 3;(12):CD007124. doi: 10.1002/14651858.CD007124.pub4. Review. Update in: Cochrane Database Syst Rev. 2016 Dec 08;12 :CD007124.

PMID:
25470302
4.

Immediate-release versus controlled-release carbamazepine in the treatment of epilepsy.

Powell G, Saunders M, Rigby A, Marson AG.

Cochrane Database Syst Rev. 2016 Dec 8;12:CD007124. doi: 10.1002/14651858.CD007124.pub5. Review.

PMID:
27933615
5.

Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.

Nolan SJ, Marson AG, Weston J, Tudur Smith C.

Cochrane Database Syst Rev. 2015 Jul 23;(7):CD001904. doi: 10.1002/14651858.CD001904.pub2. Review. Update in: Cochrane Database Syst Rev. 2016 Dec 15;12 :CD001904.

PMID:
26204241
6.

Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures.

Koch MW, Polman SK.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006453. doi: 10.1002/14651858.CD006453.pub2. Review.

PMID:
19821367
7.

Vigabatrin versus carbamazepine monotherapy for epilepsy.

Xiao Y, Gan L, Wang J, Luo M, Luo H.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD008781. doi: 10.1002/14651858.CD008781.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;11:CD008781.

PMID:
22258989
8.

Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Nolan SJ, Tudur Smith C, Weston J, Marson AG.

Cochrane Database Syst Rev. 2016 Nov 14;11:CD001031. Review.

PMID:
27841445
9.

Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.

Nevitt SJ, Marson AG, Weston J, Tudur Smith C.

Cochrane Database Syst Rev. 2017 Feb 27;2:CD001911. doi: 10.1002/14651858.CD001911.pub3. Review.

PMID:
28240353
10.

Vigabatrin versus carbamazepine monotherapy for epilepsy.

Xiao Y, Gan L, Wang J, Luo M, Luo H.

Cochrane Database Syst Rev. 2015 Nov 18;(11):CD008781. doi: 10.1002/14651858.CD008781.pub3. Review.

PMID:
26580100
11.

Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.

Nolan SJ, Marson AG, Weston J, Tudur Smith C.

Cochrane Database Syst Rev. 2016 Dec 15;12:CD001904. doi: 10.1002/14651858.CD001904.pub3. Review.

PMID:
27976799
12.

Oxcarbazepine versus phenytoin monotherapy for epilepsy.

Muller M, Marson AG, Williamson PR.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003615. Review. Update in: Cochrane Database Syst Rev. 2013;5:CD003615.

PMID:
16625587
13.

Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.

Nolan SJ, Marson AG, Weston J, Tudur Smith C.

Cochrane Database Syst Rev. 2015 Aug 14;(8):CD001911. doi: 10.1002/14651858.CD001911.pub2. Review. Update in: Cochrane Database Syst Rev. 2017 Feb 27;2:CD001911.

PMID:
26275105
14.

KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy.

Trinka E, Marson AG, Van Paesschen W, Kälviäinen R, Marovac J, Duncan B, Buyle S, Hallström Y, Hon P, Muscas GC, Newton M, Meencke HJ, Smith PE, Pohlmann-Eden B; KOMET Study Group.

J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1138-47. doi: 10.1136/jnnp-2011-300376. Epub 2012 Aug 29.

PMID:
22933814
15.

A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.

Marson AG, Appleton R, Baker GA, Chadwick DW, Doughty J, Eaton B, Gamble C, Jacoby A, Shackley P, Smith DF, Tudur-Smith C, Vanoli A, Williamson PR.

Health Technol Assess. 2007 Oct;11(37):iii-iv, ix-x, 1-134.

16.
17.

Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review.

Nolan SJ, Sudell M, Tudur Smith C, Marson AG.

Cochrane Database Syst Rev. 2016 Dec 6;12:CD012065. doi: 10.1002/14651858.CD012065.pub2. Review.

PMID:
27922722
18.

Which anticholinergic drug for overactive bladder symptoms in adults.

Madhuvrata P, Cody JD, Ellis G, Herbison GP, Hay-Smith EJ.

Cochrane Database Syst Rev. 2012 Jan 18;1:CD005429. doi: 10.1002/14651858.CD005429.pub2. Review.

PMID:
22258963
19.

Comparison of antiepileptic drugs, no treatment, or placebo for children with benign epilepsy with centro temporal spikes.

Tan HJ, Singh J, Gupta R, de Goede C.

Cochrane Database Syst Rev. 2014 Sep 5;(9):CD006779. doi: 10.1002/14651858.CD006779.pub2. Review.

PMID:
25190506
20.

Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child.

Bromley R, Weston J, Adab N, Greenhalgh J, Sanniti A, McKay AJ, Tudur Smith C, Marson AG.

Cochrane Database Syst Rev. 2014 Oct 30;(10):CD010236. doi: 10.1002/14651858.CD010236.pub2. Review.

PMID:
25354543

Supplemental Content

Support Center